T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.31B |
| 2 |
Apple
AAPL
|
+$1.58B |
| 3 |
Sherwin-Williams
SHW
|
+$1.37B |
| 4 |
HubSpot
HUBS
|
+$1.32B |
| 5 |
Kenvue
KVUE
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.37B |
| 2 |
Lam Research
LRCX
|
+$1.54B |
| 3 |
Applied Materials
AMAT
|
+$1.33B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.19B |
| 5 |
Halliburton
HAL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.32% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CPRX
951
DELISTED
Catalyst Pharmaceutical
CPRX
| $24.5M | ﹤0.01% |
1,234,383
+1,531
| +0.1% | +$28.4K |
|
952
iShares Core S&P 500 ETF
IVV
$910B
| $24.5M | ﹤0.01% |
42,405
+11,582
| +38% | +$6.44M |
|
953
Academy Sports + Outdoors
ASO
$3.05B
| $24.4M | ﹤0.01% |
417,963
-13,483
| -3% | -$736K |
|
954
Williams-Sonoma
WSM
$28.9B
| $24.3M | ﹤0.01% |
156,961
+5,319
| +4% | +$763K |
|
955
W.R. Berkley
WRB
$25.9B
| $24.2M | ﹤0.01% |
427,328
+11,979
| +3% | +$673K |
|
956
Bilibili
BILI
$7.14B
| $24.1M | ﹤0.01% |
+1,029,463
| New | +$16M |
|
957
Teleflex
TFX
$5.82B
| $23.9M | ﹤0.01% |
96,583
+2,875
| +3% | +$671K |
|
958
Endava
DAVA
$162M
| $23.8M | ﹤0.01% |
932,251
-213,221
| -19% | -$6.4M |
|
959
RB Global
RBA
$16B
| $23.8M | ﹤0.01% |
295,295
-56,584
| -16% | -$4.59M |
|
|
JNPR
960
DELISTED
Juniper Networks
JNPR
| $23.7M | ﹤0.01% |
608,209
+149,554
| +33% | +$5.71M |
|
961
F5
FFIV
$24B
| $23.4M | ﹤0.01% |
106,418
+24,512
| +30% | +$4.75M |
|
962
Laureate Education
LAUR
$5.1B
| $23.3M | ﹤0.01% |
1,399,933
+67,769
| +5% | +$1.04M |
|
|
GBIO
963
DELISTED
Generation Bio
GBIO
| $23.1M | ﹤0.01% |
935,159
-16,204
| -2% | -$429K |
|
964
Applied Industrial Technologies
AIT
$13B
| $23.1M | ﹤0.01% |
103,397
+66,551
| +181% | +$13.6M |
|
965
Jabil
JBL
$38.4B
| $23M | ﹤0.01% |
192,092
-9,458
| -5% | -$1.03M |
|
966
Jacobs Solutions
J
$17B
| $22.8M | ﹤0.01% |
176,234
-34,087
| -16% | -$4.11M |
|
967
BJs Wholesale Club
BJ
$11.8B
| $22.8M | ﹤0.01% |
276,885
+23,869
| +9% | +$2.02M |
|
968
Healthpeak Properties
DOC
$14.2B
| $22.8M | ﹤0.01% |
995,245
+17,955
| +2% | +$387K |
|
969
Atour Lifestyle Holdings
ATAT
$4.6B
| $22.7M | ﹤0.01% |
874,696
+2,737
| +0.3% | +$50.9K |
|
970
TriNet
TNET
$3.07B
| $22.6M | ﹤0.01% |
232,787
-11,846
| -5% | -$1.18M |
|
971
CG Oncology
CGON
$6.62B
| $22.3M | ﹤0.01% |
591,407
-73,738
| -11% | -$2.59M |
|
972
Pentair
PNR
$10.5B
| $22.3M | ﹤0.01% |
227,757
+4,859
| +2% | +$416K |
|
973
Trimble
TRMB
$13.4B
| $21.9M | ﹤0.01% |
353,175
+1,804
| +0.5% | +$101K |
|
974
A.O. Smith
AOS
$8.51B
| $21.7M | ﹤0.01% |
241,169
+5,486
| +2% | +$454K |
|
975
Alliant Energy
LNT
$18.2B
| $21.6M | ﹤0.01% |
356,720
+10,652
| +3% | +$605K |
|
Similar funds
T. Rowe Price Associates's Q3 2024 Portfolio in Review
As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
- T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
- T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
- T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.
Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.